JMJaspreet Mahindroo

Jaspreet Mahindroo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaspreet Mahindroo has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Amplicon sequencing for Salmonella Paratyphi A detection v2

    by Jaspreet Mahindroo, Anton Spadar, Catherine Troman, Zoe Dyson, Kathryn Holt, Nick Grassly

    This protocol outlines the workflow for direct detection of Salmonella Paratyphi A in wastewater and is applied only to samples that have already undergone screening with the https://dx.doi.org/10.17504/protocols.io.8epv5zrw4v1b/v4 qPCR assay, with all ttr‑positive extracts subsequently processed using the methods described here.

  • Open Access

    Amplicon Sequencing for Genotyping S. Typhi v2

    by Jaspreet Mahindroo, Anton Spadar, Catherine Troman, Zoe Dyson, Kathryn Holt, Nick Grassly

    The following protocol is for amplifying and sequencing amplicons targeting Salmonella enterica serovar Typhi (S. Typhi). It is primarily for use with samples that are already suspected to be positive for S. Typhi and has been designed for use with DNA extracted from environmental surveillance samples. The resulting sequences can be analysed and used for genotyping (given that the genotype is targeted by the primer panel) and determining antimicrobial resistance. The genotypes targeted in the panel in this protocol are listed but primers can be designed for other S. Typhi genotypes of interest. The library preparation steps of this protocol are adapted from the Oxford nanopore protocol "Ligation Sequencing Amplicons - Native Barcoding Kit 24 V14 (SQK-NBD114.24)" which is available on the Nanopore community.

  • Open Access

    Generating Ct cut-off values using gBlocks gene fragments v2

    by Jonathan Rigby, Catherine Troman, Jaspreet Mahindroo, Alex Shaw, Dilip Abraham, Nick Grassly

    The following protocol describes the resuspension, dilution, and qPCR of gBlocks gene fragments. gBlocks gene fragments are synthesised double stranded DNA oligos, which can be used for standardisation. In this protocol, the standard curves generated by the gBlocks in a triplex qPCR are used to determine a Ct cut-off value for the S. Typhi gene targets (ttr, tviB, staG, C6) and the HF183 Bacteroides rRNA gene.

  • Open Access

    Environmental sampling using Moore swabs v2

    by Jonathan Rigby, Catherine Troman, Dilip Abraham, Jaspreet Mahindroo, Jacob John, Venkata Raghava Mohan, Rajan Srinivasan, Nicolette Zhou, Satheesh Nair, Alex Shaw, et al.

    A protocol for the collection of environmental samples (sewage and wastewater) using Moore swabs and subsequent laboratory processing up to DNA extraction. This is part of a set of protocols for environmental surveillance of Salmonella Typhi. Bacteria in the wastewater are trapped in the Moore swab. Trapped bacteria are enriched during incubation in Universal Pre-Enrichment broth. The broth is then filtered under a vacuum to capture the bacteria on filter discs ready for DNA extraction. This protocol is adapted from the Moore swab protocol described in Liu et al (2021).

  • Open Access

    Extraction and qPCR of Environmental Surveillance samples for the detection of Salmonella Typhi v2

    by Jonathan Rigby, Catherine Troman, Dilip Abraham, Jaspreet Mahindroo, Christopher Uzzell, Jacob John, Venkata Raghava Mohan, Rajan Srinivasan, Nicolette Zhou, Satheesh Nair, et al.

    The following protocol is for use on environmental samples that have been collected by Moore swab or grab sampling methods and processed up to the stage of DNA extraction. The protocol includes DNA extraction and qPCR analysis of the samples to detect three gene targets for identifying Salmonella Typhi, a human faecal indicator (HF183), and a commercial spike-in control. The qPCR uses fluorescence of Taqman probes for measuring the product. Care must be taken to ensure that the fluorescent dyes chosen for the probes are suitable for the machine being used or can be calibrated for use on the machine. If the dyes selected are different from those described in the protocol, make sure that their excitation/emission spectra do not overlap to avoid crossover between targets. Generation of standard curves is mentioned in this protocol but is described in more detail in a separate protocol in the Typhoid ES workspace.

  • Open Access

    Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced Acinetobacter baumannii

    by Munawr AL Quraini, Zaaema AL Jabri, Hiba Sami, Jaspreet Mahindroo, Neelam Taneja, Zakariya AL Muharrmi, Ibrahim AL Busaidi, Meher Rizvi

    Background: The diminishing antimicrobial options for the treatment of XDR and PDR Acinetobacter baumannii is an increasing concern. In this study, we assessed the in vitro synergy of the fosfomycin (FOS) with meropenem (MEM), amikacin (AK), tigecycline (TGC), and colistin (CL) in whole genome sequenced isolates. Methods: Non-replicate whole genome sequenced (illumina next-generation sequencing platform, Clevergene, India), A. baumanii (7 XDR, 1PDR) were subjected to in vitro synergy testing by checkerboard (CB) and time kill assay (TKA) after MIC determination, with glucose-6-phosphate being incorporated in all runs. FOS was used as a cornerstone drug in four combinations and colistin in one. ResFinder, MLST, PlasmidFinder, and CSIPhylogeny tools were used. Results: Mortality occurred in three patients. Diverse MLST were observed, ST-1962 (3 isolates) and one each of ST2062, ST2063, ST1816, ST1806, ST234. FOS MICs ranged from 32 to 128 mg/L, MEM MIC: 16–64 mg/L, TGC MIC: ≤2–≤4 mg/L and AK MIC: >512 mg/L. CL: MIC range, 0.25–≤2 mg/L, PDR MIC > 16 mg/L. Synergy results by CB: FOS-MEM: synergy in ⅞ (90%) isolates. Synergy lowered MEM MICs to susceptibility breakpoints in 6/8 cases. CL-MEM: Excellent synergy (3/3) isolates. FOS-AK: Indifference in ⅞, antagonism ⅛ (AK-susceptible isolate). FOS-TGC: Partial synergy (PS) in 8/8 (TGC MIC dropped to ≤0.25 mg/L in 3/8). In the PDR isolate, synergy was seen in FOS-MEM, CL-MEM, PS in FOS-CL, FOS-TGC, indifference in FOS-AK. TKA: Excellent synergy was observed with FOS-MEM from 4 h, while FOS-AK and FOS-TGC demonstrated synergy at 24 h. Synergy was achieved despite presence of widespread resistance markers against aminoglycosides (AacAad, AadA, AadB, Aph3″Ia, ArmA, Arr, StrA, StrB), beta-lactams (ADC, BlaA1, BlaA2, Zn-dependent_hydrolase, OXA-23, OXA-51, PER-1,TEM-1D, CARB-5, Mbl), sulphonamides (SulII, SulI), phenicols (CatBx, CmlA), macrolides (MphE, MsrE) and tetracycline (TetB) were widespread. Carbapenemase, CARB-5 was present in one isolate. Beta-lactamase genes OXA-23, OXA-51, BlaA2, Zn-dependent_hydrolase, ADC, Mbl and macrolide resistance genes MphE, MsrE were present in all 8 isolates. Conclusions: FOS-MEM and CL-MEM are promising combinations against A. baumannii. Synergy of FOS-MEM in intrinsically resistant A. baumannii shows that this antibiotic combination might be useful in treating such XDR and PDR pathogens.


  • Phenotypic and genotypic characterization of antimicrobial resistance in clinical isolates of Vibrio cholerae over a decade (2002-2016)

    by Parakriti Gupta, Vinay Modgil, Vishal Kant, Harpreet Kaur, Chandradeo Narayan, Jaspreet Mahindroo, Ritu Verma, Balvinder Mohan, Neelam Taneja


  • Open Access

    Comparative analysis of virulence determinants, phylogroups, and antibiotic susceptibility patterns of typical versus atypical Enteroaggregative E. coli in India

    by Vinay Modgil, Jaspreet Mahindroo, Chandradeo Narayan, Manmohit Kalia, Yousuf, Varun Shahi, Meenakshi Koundal, Pankaj Chaudhary, Ruby Jain, Kawaljeet Singh Sandha, et al.

    Enteroaggregative Escherichia coli (EAEC) is an evolving enteric pathogen that causes acute and chronic diarrhea in developed and industrialized nations in children. EAEC epidemiology and the importance of atypical EAEC (aEAEC) isolation in childhood diarrhea are not well documented in the Indian setting. A comparative analysis was undertaken to evaluate virulence, phylogeny, and antibiotic sensitivity among typical tEAEC versus aEAEC. A total of 171 EAEC isolates were extracted from a broad surveillance sample of diarrheal (N = 1210) and healthy children (N = 550) across North India. Polymerase chain reaction (PCR) for the aggR gene (master regulator gene) was conducted to differentiate tEAEC and aEAEC. For 21 virulence genes, we used multiplex PCR to classify possible virulence factors among these strains. Phylogenetic classes were identified by a multiplex PCR for chuA, yjaA, and a cryptic DNA fragment, TspE4C2. Antibiotic susceptibility was conducted by the disc diffusion method as per CLSI guidelines. EAEC was associated with moderate to severe diarrhea in children. The prevalence of EAEC infection (11.4%) was higher than any other DEC group (p = 0.002). tEAEC occurrence in the diarrheal group was higher than in the control group (p = 0.0001). tEAEC strain harbored more virulence genes than aEAEC. astA, aap, and aggR genes were most frequently found in the EAEC from the diarrheal population. Within tEAEC, this gene combination was present in more than 50% of strains. Also, 75.8% of EAEC strains were multidrug-resistant (MDR). Phylogroup D (43.9%) and B1 (39.4%) were most prevalent in the diarrheal and control group, respectively. Genetic analysis revealed EAEC variability; the comparison of tEAEC and aEAEC allowed us to better understand the EAEC virulence repertoire. Further microbiological and epidemiological research is required to examine the pathogenicity of not only typical but also atypical EAEC.


  • Open Access

    Phenotypic and molecular characterization of antimicrobial resistant Escherichia coli from urinary tract infections in Port-Harcourt, Nigeria

    by Adebola Onanuga, Jaspreet Mahindroo, Shreya Singh, Neelam Taneja

    Multidrug resistance among Escherichia coli causing Urinary Tract Infections (UTIs) is a major public health problem, threatening the effective treatment of UTIs. This study investigated the phenotypic and molecular characteristics of E. coli associated with UTIs in Port-Harcourt, Nigeria. Twenty-five non-duplicate isolates of E. coli from UTIs patients at the University of Port-Harcourt Teaching Hospital, Nigeria were identified using Matrix-Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry. The antimicrobial susceptibility patterns were determined using Kirby-Bauer disc diffusion technique. Phenotypic expression of Extended Spectrum Beta Lactamases (ESBLs) and AmpC beta-lactamase were determined using standard laboratory methods and polymerase chain reaction (PCR) was used to detect ESBLs, AmpC, Quinolones and Aminoglycosides resistance genes. The isolates exhibited high rates of resistance to co-trimoxazole (76%), nalidixic acid (68%), ciprofloxacin (60%), gentamicin (44%) and low resistance to cefotaxime (20%) but were fully susceptible to cefoperazone/sulbactam, amikacin, nitrofurantoin, colistin and carbapenems. Phenotypic expression of ESBLs was recorded in 6(24%) isolates while genotypic detection revealed the highest prevalence of blaTEM 22(88%), followed by blaCTX-M-15 16(64%), blaSHV 7(28%) and blaOXA-1 6(24%) while AmpC (blaCMY-2) gene was detected in 8(32%) isolates. Amongst the quinolone resistant isolates, qnr variants (qnrB, qnrD and qnrS) and aac(6')-Ib genes were detected in 7(28%) and 3(12%) isolates respectively while all gentamicin resistant isolates possessed the aacC2 gene. The co-expression of blaCTX-M-15 with quinolones and aminoglycoside genes were 20% and 40% respectively. The prevalence of multiple drug resistance was 52%. A high proportion of the studied E. coli isolates co-expressed ESBLs, quinolones and aminoglycosides resistance genes which call for prompt antibiotic stewardship and preventive strategies to limit the spread of these genes.


  • Open Access

    Endemic fluoroquinolone-resistant Salmonella enterica serovar Kentucky ST198 in northern India

    by Jaspreet Mahindroo, Duy Pham Thanh, To Nguyen Thi Nguyen, Balvinder Mohan, Siddhartha Thakur, Stephen Baker, Neelam Taneja

    Salmonella e nterica serovar Kentucky is an emergent human pathogen. Human infection with ciprofloxacin-resistant S. enterica Kentucky ST198 has been reported in Europe and North America as a consequence of travel to Asia/the Middle East. This is, to the best of our knowledge, the first study reporting the identification of this epidemic clone in India and South Asia.